John Scott Dalglish, 66, passed away on June 30, 2025, at MD Anderson Cancer Center in Houston, Texas. Scott was born ...

With several important initiatives underway at Moffitt Cancer Center, one of the greatest challenges is prioritizing them in a way that is most impactful for its field and patients, said President and ...

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and ...

Exposing people with similar types of breast cancer to radiation alone led to changes in tumor and immune cells, paving the ...

Proposed cuts to the National Institutes of Health could drastically impact universities in mid-Michigan that study breast ...

I can’t tell you with full certainty that eating red meat will increase your cancer risk — only that the data is concerning ...

A biopsy later confirmed it was precancerous leukoplakia Years later, Shinkle was diagnosed with tongue cancer. Now, 41, he's ...

Three-fourths of patients with heavily pretreated diffuse large B-cell lymphoma (including with CAR T-cell therapy) responded to an investigational CAR T-cell therapy, and about half of patients had ...

The newly approved linvoseltamab (Lynozyfic; Regeneron) has a manageable safety profile, along with a patient-friendly dosing ...

Spine Medicine and Surgery of Long Island (N.Y.) has added Marissa Catalanotto, MD, to its staff.  Dr. Catalanotto is an interventional pain management physician and is currently completing a pain ...

Promising therapeutic strategies for lung cancer, AML and advanced solid tumors Novel insights into ovarian cancer, blood disorders and chemotherapy-related secondary cancers New-onset diabetes as an ...

With a $1.2 million grant from the Department of Defense, a University of Houston engineer will lead a team of researchers in finding early markers for ovarian cancer.